Judicial and legislative practice and related suggestions on off-label drug use in China
Abstract Background Off-label drug use exists widely in medical practice and is also an area which easily triggers controversy between patients and medical institutions. Previous studies have identified the reasons why off-label drug use long exists. However, there is no multidimensional analysis on...
Main Authors: | Wenjie Si, Panpan Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-023-09293-y |
Similar Items
-
The professional liability of clinicians for off-label prescriptions
by: A. Zagari
Published: (2013-05-01) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013-05-01) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
by: Weilan Wang, et al.
Published: (2013-05-01) -
Legal Responsibility of Doctor Regarding off-label Drug Applications
by: Erdal Yüzbaşıoğlu
Published: (2012-03-01) -
Guideline for the management of pediatric off-label use of drugs in China (2021)
by: Min Meng, et al.
Published: (2022-07-01)